Breaking News

You are here » Indian-Commodity  :  Top News  :  Punjab National Bank reports net loss of Rs 940.01 crore in Q1


Punjab National Bank reports net loss of Rs 940.01 crore in Q1

Punjab National Bank has reported results for first quarter ended June 30, 2018.

The Bank has reported a net loss of Rs 940.01 crore for the quarter under review as compared to net profit of Rs 343.40 crore for the same quarter in the previous year. However, total income of the Bank increased by 4.18% at Rs 15,072.41 crore for Q1FY19 as compared Rs 14,468.14 crore for the corresponding quarter previous year.

The Bank's gross NPA for the April-June quarter of the current fiscal increased to 18.26%, as compared to 13.66% in the same quarter of the previous year. Besides, Bank's Net NPA stood at 10.58% in Q1FY19.

Related News

View all news

Gold futures end higher on Tuesday

Gold futures finished higher on Tuesday, marking biggest single-session percentage rise since November, as investors increased bullion investments amid potential progress on Brexit and trade talks between......

Jeera futures trade lower on NCDEX

Jeera futures traded lower on NCDEX, as speculators reduced exposure on account of reduced export demand in the physical market. Moreover, expectation of higher production due to adequate availability......

Copper futures end higher on weaker dollar

Copper futures ended higher on Tuesday due to a weaker US dollar and hopes that the United States and China would forge a trade deal. A new round of talks between the United States and top metals consumer......

Top News

View all news

Tata Motors signs LTS agreement with its employees

Tata Motors has signed a long-term wage settlement (LTS) agreement with its employees. Under the agreement, workmen will get a wage rise of Rs 9,000 per month along with other incentives based on performance.......

Canara Bank invites bids from merchant bankers to manage its $350-500 million MTN issue: Report

Canara Bank has reportedly invited bids from merchant bankers to manage its $350-500 million issue of senior unsecured/tier-II capital bonds under its medium-term note (MTN) programme. The issue size may......

Alembic Pharma gets USFDA's nod for Acetazolamide Extended-Release Capsules

Alembic Pharmaceuticals (Alembic) has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Acetazolamide Extended-Release Capsules, 500......